Skin Beauty Filler Biotech Co., Ltd.

Nabota 100 iu Lyophilized Powder for Injection Purified Neurotoxin Complex Formulation: Each vial contains: 100 iu THERAPEUTIC INDICATIONS Botulinum Toxin Type A (Nabota) is indicated for the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm, hemifacial spasm or VIIth nerve disorders in patients 12 years or older. Botulinum Toxin Type A (Nabota) is indicated for the correction of strabismus in patients 12 years or older. Botulinum Toxin Type A (Nabota) is indicated for the treatment of spasmodic torticollis (cervical dystonia) in adults. Botulinum Toxin Type A (Nabota) is indicated for the treatment of dynamic equinus foot deformity due to spasticity in pediatric cerebral palsy patients, two years of age or older. Botulinum Toxin Type A (Nabota) is indicated for the temporary treatment of glabellar lines associated with corrugator and/or procerus muscle activity in adult patients below 65 years of age. Botulinum Toxin Type A (Nabota) is indicated in the management of focal spasticity, including the treatment of spasticity associated with stroke in adults. Botulinum Toxin Type A (Nabota) is indicated for the treatment of focal hyperhidrosis of the axilla. Botulinum Toxin Type A (Nabota) is indicated for the temporary improvement in the appearance of upper facial rhytides (glabellar lines, crow’s feet and forehead lines) in adults. Botulinum Toxin Type A (Nabota) is indicated for the prophylaxis of headaches in adults with chronic migraine. Botulinum Toxin Type A (Nabota) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults. Email:skinbeautyfiller(at)yahoo(dot)com Wechat:lilyflowerbeauty